Pfizer Sticks to 2025 Profit View as It Shrugs off Plunging Paxlovid Sales for COVID
Pfizer Stock's 7% Yield Makes It Look Like a Junk Bond -- But Better -- Barrons.com
Sector Update: Health Care
Pfizer CEO Says Tariff Uncertainty Is Deterring Further U.S. Investment in Manufacturing, R&D
Pfizer Shares Are Trading Higher Following a Q1 EPS Beat. The Company Reaffirmed Guidance but Said It Is Trending Towards the Upper End of Its 2025 Adjusted Diluted EPS Guidance Range.
Express News | Pfizer Shares Are Trading Higher Following a Q1 EPS Beat. The Company Reaffirmed Guidance but Said It Is Trending Towards the Upper End of Its 2025 Adjusted Diluted EPS Guidance Range
Stocks Making the Biggest Moves Midday: Spotify, General Motors, Royal Caribbean, Pfizer and More
Dow Boosted by Honeywell, Sherwin-Williams While S&P and Nasdaq Seesaw
Express News | Live On CNBC Josh Brown Announces Sold Some Pfizer
Express News | Pfizer Shares Reverse Course, Last up 4.3%
Top Midday Stories: Amazon Says Listing Tariff Pricing Never Considered for Main Site; Novo Nordisk Partners With Hims on Wegovy
Unusual Options Activity: HSBC, CRH and Others Attract Market Bets, HSBC V/OI Ratio Reaches 88.9
Express News | Pfizer CEO Bourla Says Co "Not Going to Be a Strong Top Line Growth Story for Next Three Years, Given Loes, We Expect to Become EPS Growth Story"
Pfizer Reports Mixed First Quarter, Affirms Full-Year Outlook
Express News | Pfizer CEO Says Co Has "Ample Room if There Is a Need to Transfer Production" of Medicines to United States - Conf Call
Pfizer Offers 'Longer-term' Opportunity Amid Tariff Uncertainty
Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key Metrics
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Phathom Pharmaceuticals (PHAT) and Exact Sciences (EXAS)
4 Stocks to Watch on Tuesday: KO, PFE, GM and UPS
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday